BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18712951)

  • 1. Maternal thrombophilias are associated with specific placental lesions.
    Gogia N; Machin GA
    Pediatr Dev Pathol; 2008; 11(6):424-9. PubMed ID: 18712951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental fetal vascular thrombosis lesions and maternal thrombophilia.
    Beeksma FA; Erwich JJ; Khong TY
    Pathology; 2012 Jan; 44(1):24-8. PubMed ID: 22173239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report.
    Weber MA; Nikkels PG; Hamoen K; Duvekot JJ; de Krijger RR
    Pediatr Dev Pathol; 2006; 9(3):234-8. PubMed ID: 16944973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetric and perinatal complications in placentas with fetal thrombotic vasculopathy.
    Saleemuddin A; Tantbirojn P; Sirois K; Crum CP; Boyd TK; Tworoger S; Parast MM
    Pediatr Dev Pathol; 2010; 13(6):459-64. PubMed ID: 20438299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence.
    Katzman PJ; Genest DR
    Pediatr Dev Pathol; 2002; 5(2):159-64. PubMed ID: 11910510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?
    Leistra-Leistra MJ; Timmer A; van Spronsen FJ; Geven WB; van der Meer J; Erwich JJ
    Placenta; 2004 Apr; 25 Suppl A():S102-5. PubMed ID: 15033316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is thrombophilia a risk factor for placental vascular disorders?].
    Borg JY
    Ann Med Interne (Paris); 2003; 154(5-6):325-31. PubMed ID: 15027586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia and placental pathology.
    Redline RW
    Clin Obstet Gynecol; 2006 Dec; 49(4):885-94. PubMed ID: 17082683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature.
    Al-Adnani M; Kiho L; Scheimberg I
    Pediatr Dev Pathol; 2008; 11(3):226-9. PubMed ID: 17990939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin.
    Katz VL; DiTomasso J; Farmer R; Carpenter M
    Am J Perinatol; 2002 Jul; 19(5):273-7. PubMed ID: 12152146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.
    Arias F; Romero R; Joist H; Kraus FT
    J Matern Fetal Med; 1998; 7(6):277-86. PubMed ID: 9848693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive perivillous fibrin deposition, chronic histiocytic intervillositis and villitis of unknown etiology: Lesions of the placenta at the fetomaternal interface with risk of recurrence].
    Feist H; Blöcker T; Hussein K
    Pathologe; 2015 Jul; 36(4):355-61. PubMed ID: 25613921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental pathology in fetal thrombophilia.
    Ariel I; Anteby E; Hamani Y; Redline RW
    Hum Pathol; 2004 Jun; 35(6):729-33. PubMed ID: 15188139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for thrombophilias: indications and controversies.
    Carbone JF; Rampersad R
    Clin Lab Med; 2010 Sep; 30(3):747-60. PubMed ID: 20638586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition.
    Uxa R; Baczyk D; Kingdom JC; Viero S; Casper R; Keating S
    Placenta; 2010 Jun; 31(6):499-505. PubMed ID: 20447686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of thrombophilia with fetal growth restriction.
    Jamal A; Hantoshzadeh S; Hekmat H; Abbasi S
    Arch Iran Med; 2010 Nov; 13(6):482-5. PubMed ID: 21039002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of the placenta. Case 7. Massive perivillous fibrin deposits (maternal floor infarct)].
    Pelluard F
    Ann Pathol; 2010 Aug; 30(4):306-9. PubMed ID: 20837242
    [No Abstract]   [Full Text] [Related]  

  • 18. Massive perivillous fibrin deposition: Diagnosis, obstetrical features, and treatment.
    Cheloufi M; Coulomb A; Abisror N; Kayem G; Fain O; Alijotas-Reig J; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():125-132. PubMed ID: 37995528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in long-chain 3-hydroxyacyl coenzyme a dehydrogenase are associated with placental maternal floor infarction/massive perivillous fibrin deposition.
    Griffin AC; Strauss AW; Bennett MJ; Ernst LM
    Pediatr Dev Pathol; 2012; 15(5):368-74. PubMed ID: 22746996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation disorders in pregnancy: acquired and inherited thrombophilias.
    Benedetto C; Marozio L; Tavella AM; Salton L; Grivon S; Di Giampaolo F
    Ann N Y Acad Sci; 2010 Sep; 1205():106-17. PubMed ID: 20840261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.